Date Name Title Filing Type Shares Traded Price Total Held
Dec 16, 2016
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 146,815 -- 146,815
Dec 16, 2015
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 146,815 -- 146,815
Jan 03, 2019
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Bona fide gift 569 -- 146,844
Nov 06, 2006
Director, Chief Exec Officer & President, Ten Percent Owner
Director, Chief Exec Officer & President, Ten Percent Owner Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 47,535 $22.25 147,144
Oct 04, 2018
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Bona fide gift 521 -- 147,413
Feb 28, 2008
Director
Director Form 4 Other acquisition or disposition -- -- 147,505
Dec 19, 2007
Director
Director Form 4 Other acquisition or disposition -- -- 147,505
Jun 29, 2007
Director
Director Form 4 Other acquisition or disposition -- -- 147,505
Jun 20, 2007
Director
Director Form 4 Other acquisition or disposition (describe transaction) 72,296 -- 147,505
Nov 22, 2011
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 15,000 $28.81 147,772

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.